Preeti Patel, MD
Critical Care Medicine · Mattoon, ILNPI 1336580273
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 89.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $8,271 and has fallen 64.3% since, to $2,957 in 2025. Among critical care medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $189.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- Pulmonx Corporation$532
- Phathom Pharmaceuticals, Inc.$224
- GSK$136
- Abbott$91
- Boehringer Ingelheim$88
- plus $209 from 8 others
What the payments were for
- Travel & lodging$4,55738%
- Food & beverage$1,88216%
- Education$5,50046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 39 | $10,659 |
| Pulmonx Corporation | 4 | $532 |
| Phathom Pharmaceuticals, Inc. | 3 | $224 |
| GSK | 4 | $136 |
| Abbott | 1 | $91 |
| Boehringer Ingelheim | 2 | $88 |
| Genentech USA, Inc. | 1 | $39 |
| Novo Nordisk | 2 | $37 |
| Sanofi | 2 | $32 |
| Merck | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Baxter Healthcare | 1 | $20 |
| Viatris Specialty LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,938 in reported general payments places this provider in the 90th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $48,926 |
| Spiriva RespimatTiotropium Bromide | 26 | $22,826 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $11,289 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $10,606 |
| Incruse ElliptaUmeclidinium Bromide | 19 | $8,480 |
| SymbicortBudesonide/Formoterol Fumarate | 29 | $7,356 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $6,077 |
| Spiriva HandihalerTiotropium Bromide | 12 | $5,928 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $2,380 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,334 |
| Ventolin HfaAlbuterol Sulfate | 13 | $928 |
| Azithromycin | 28 | $828 |
| Montelukast Sodium | 23 | $293 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta | $136 | $63,48293 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $88 | $34,11446 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 281 critical care medicine providers in Illinois.
Other critical care medicine in Mattoon
- Maamoun ZaneMattoon$4K
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$402K
- Daniel DillingMaywood$208K
- Israel RubinsteinChicago$107K
- John RickelmanQuincy$90K
- Abbas Al-QamariChicago$40K
- Husam NayefPalos Park$24K
- Nureain MirzaOak Lawn$22K
- Edward GarrityBurr Ridge$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.